Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosa
Citations Over TimeTop 10% of 1999 papers
Abstract
We conducted a case-series study of multiresistant Pseudomonas aeruginosa in patients who did not have cystic fibrosis. Patient characteristics, antibiotic exposures, time course of emergence of resistance, and clinical outcomes were examined. Twenty-two patients were identified from whom P. aeruginosa resistant to ciprofloxacin, imipenem, ceftazidime, and piperacillin was isolated. Nineteen (86%) had clinical infection. Patients received prolonged courses of antipseudomonal antibiotics before isolation of multiresistant P. aeruginosa. Nine of 11 patients with soft-tissue infection exhibited resolution of clinical infection but usually required surgical removal of infected tissue with or without revascularization. Overall, three patients died. In two instances in which multiple isolates with different susceptibility profiles from the same patient were available, pulsed-field gel electrophoresis profiles of serial isolates were indistinguishable or closely related. This study illustrates that multiresistant P. aeruginosa emerges in a stepwise manner after exposure to antipseudomonal antibiotics and results in adverse outcomes.
Related Papers
- → Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa(2017)18 cited
- → Virulence of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa In Vitro and In Vivo(2004)25 cited
- → Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin inPseudomonas aeruginosa isolates from bacteremic patients(1996)7 cited
- Comparison of antibiomicrobial susceptibility and PAE of antibiotics treated infections of Pseudomonas aeruginosa.(2004)
- Effect of macrolides and ciprofloxacin, ceftazidime on biofilm of pseudomonas aeruginosa(2005)